Mechanistic insight into the treatment of diabetes: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of insulin receptor substrate-1 (IRS-1) via up regulation of its target gene, 4/April/2014, 22.47

Mechanistic insights into tumorigenesis: Activator Protein-1 inhibits the expression of tumor suppressor GRHL3 via up regulation of its target gene, 3/April/2014, 22.35
April 3, 2014
Mechanistic insight into the treatment of diabetes: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of IGF-IR via up regulation of its target gene, 4/April/2014, 22.48
April 3, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Mechanistic insight into the treatment of diabetes: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of  insulin receptor substrate-1 (IRS-1) via up regulation of its target gene, 4/April/2014, 22.47,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.